Kodiak Sciences (KOD) 10-Q2021 Q1 Quarterly report

Filed: 10 May 21, 5:13pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Addendum, affiliated, aflibercept, anesthesiologist, annum, ballot, begun, Beovu, Biden, Britain, broader, broadest, choroidal, CMC, codification, constitutionality, convertible, CPRA, credential, cybercrime, cybersecurity, DAYLIGHT, deal, delete, deny, distancing, diverge, dosage, Edition, engine, engineering, espionage, ESPP, expansion, exploited, faricimab, Felix, fundamentally, genetic, Germany, hacking, honor, iii, immaterial, incident, instructed, Israel, legislature, lesser, life, malware, mechanism, merge, MHRA, molecular, myopic, nationwide, neovascularization, NMPA, Northern, notify, overturning, path, perspective, phishing, pipette, plant, preliminary, principle, proportion, qualification, ransomware, ratably, reconsider, redeemable, regime, resale, scarce, slightly, slower, social, softer, spanning, sterile, stuffing, syringe, tariff, topline, transmit, twelve, unexpected, unnecessary, uptake, vaccine, waiver, window

Removed: acceleration, accrete, achieved, activate, activated, advisory, affecting, affinity, afford, allotted, alveolar, Ancillary, Arrangement, assembling, assessed, attestation, audit, auditor, avoiding, balance, basket, Bay, billion, blockade, Blueprint, branch, building, built, calendar, cancelable, capped, certiorari, clinic, cloud, CMS, codified, component, computing, confirmed, constant, continually, convince, cyber, damaged, devoted, differentiated, direct, documented, dosed, dysfunction, effector, elevated, emerging, enable, Endothelial, enthusiasm, essentially, establishment, exemplified, exemption, explored, extraordinary, Factor, fall, Fc, finance, firm, footing, fourth, Francisco, functioning, fusion, GMP, golden, hacker, harder, HHS, holding, home, hour, immune, immunologic, immunologically, implicated, implicit, improved, improvement, impute, imputed, inappropriate, inducer, inert, inflammatory, inhibition, inhibitor, interleukin, intermediate, intersection, Intriguingly, irrevocable, irrevocably, Jumpstart, kidney, lend, letter, licensure, listed, logistical, lung, manageable, marginal, matched, meaningfully, mediated, modification, narrowing, Nasdaq, NDA, necessitated, nonbinding, NPDR, opening, ophthalmology, opt, optimized, oral, paired, parachute, partnering, pathological, payable, periodically, permeability, pocket, predictable, proceed, project, proposal, protein, pulmonary, ranging, rating, reaction, recovery, refer, reflection, registrational, remained, repay, repurchased, resultant, role, rotation, running, San, scaled, secure, Simplifying, Society, sophistication, specificity, step, Street, Subtopic, supplement, supporting, switch, synergistic, systemically, testament, thoughtful, tissue, top, Topic, unique, unobservable, unrealized, Updated, upfront, upgraded, usage, validate, view, Wall, weighted, worsening

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

KOD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Kodiak Sciences Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2021

By:

/s/ John Borgeson

John Borgeson

Senior Vice President and Chief Financial Officer

(Principal Accounting and Financial Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.